Categories

Ibrance (palbociclib), Kisqali (ribociclib), and Verzenio (abemaciclib): Drug Safety Communication – Due to Rare but Severe Lung Inflammation

FDA is warning that Ibrance (palbociclib), Kisqali (ribociclib), and Verzenio (abemaciclib) used to treat some patients with advanced breast cancers may cause rare but severe inflammation of the lungs.

http://www.fda.gov/safety/medwatch-safety-alerts-human-medical-products/ibrance-palbociclib-kisqali-ribociclib-and-verzenio-abemaciclib-drug-safety-communication-due-rare

 
Categories

Fecal Microbiota for Transplantation: Safety Communication- Risk of Serious Adverse Reactions Due to Transmission of Multi-Drug Resistant Organisms

FDA MedWatch Alert regarding Fecal Microbiota for Transplantation: Safety Communication- Risk of Serious Adverse Reactions Due to Transmission of Multi-Drug Resistant Organisms

http://www.fda.gov/safety/medwatch-safety-alerts-human-medical-products/fecal-microbiota-transplantation-safety-communication-risk-serious-adverse-reactions-due

 
Categories

Suspendidas las visitas en cinco centros penitenciarios ante brote de paperas

Suspendidas las visitas en cinco centros penitenciarios ante brote de paperas

Salud atiende brote de parotiditis en cuatro centros penitenciarios12 de setiembre del 2019. Ante el brote de parotiditis presentado semanas anteriores en cinco Centros de Atención Integral del país, el Ministerio de Salud, a través de sus áreas cantonales

https://www.ministeriodesalud.go.cr/index.php/noticias/noticias-2019/1477-suspendidas-las-visitas-en-cinco-centros-penitenciarios-ante-brote-de-paperas